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Background and objectives:  
The use of antibiotic growth promoters (AGP) in animal feed is prohibited in the European Union 
(regulation [EC] no. 1831/2003) due to the risk of developing resistance to antibiotics in human 
consumers. However, natural feed additives such as mannan oligosaccharides (MOS) are promising 
alternatives to AGP. MOS, natural substances obtained from cell walls of yeast and plants, have 
health-promoting effects as they have potential prebiotic properties. Salmosan® (S-βGM) is a 
hydrolyzed and highly β-galactomannan-rich MOS product developed from the carob bean of the 
Ceratonia siliqua tree and guar bean of Cyamopsis tetragonoloba. 
Methodology:  
We have studied the effect of S-βGM in chicken intestine and in an in vitro model of intestinal 
Caco-2 cells in culture. 
Results and conclusions:  
We have found that dietary supplementation with S-βGM in chickens infected with Salmonella 
Enteritidis increases mucus production and preve  nts ZO-1 delocalization. These are effects 
associated with improved intestinal barrier function. Moreover, in Caco-2 cell cultures, we have 
confirmed the capacity of S-βGM to agglutinate Salmonella Enteritidis and to prevent epithelial 
barrier function disruption induced by the bacterium colonization. Furthermore, we have 
demonstrated that in combination with Lactobacillus plantarum, a recognized probiotic accepted to 
be used as an additive in animal nutrition (EFSA regulation [EC] no. 1831/2003), restores intestinal 
barrier function disrupted by TNF-α and LPS in co-cultures of Caco-2 cells and macrophages. This 
protective effect could be related to the modulation of cytokine production and to the fact that S-
βGM increases the growth of Lactobacillus plantarum. 
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